Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Bispecifics

AstraZeneca Buys T Cell Engager for $100 Million

Pharma giant makes a major investment in improving the standards of care in B cell malignancies.
Read More
Proteins & Antibodies

Recommended Approval for AbbVie’s Rinvoq Treatment

AbbVie announces official recommended approval of it Rinvoq treatment for adults with active non-radiographic axial spondyloarthritis.
Read More
Biologics Analysis

The Countdown Begins: How ADCs will Become the Next Generation of Biologics Therapeutics

Key opinion leaders from AbbVie, Ambrx Inc, and Antikor Biopharma talk about the cutting-edge technology’s promise for better therapeutic index.
Read More
Bispecifics

Why Drug Delivery is Key to New Drug Discovery

Method of delivery is just as important as discovering new medicines.
Read More
Vaccines

Q & A with Derek O'Hagan

We interview Derek O'Hagan, Senior Advisor at GlaxoSmithKline Vaccines to learn more about the future of the vaccine.
Read More
Vaccines

Polio Resurgence Hits UK

The poliovirus is on the rise for the first time in nearly 40 years.
Read More
Vaccines

Most Anticipated Presentations: Vaccines Europe

Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
Read More
Peptides

Oral Delivery of Peptides

Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.
Read More
Proteins & Antibodies

Top 3 Biologics News Headlines

Hot off the press, we look at this week’s breaking news stories from the Biologics industry.
Read More
Proteins & Antibodies

Delays for New COVID Drugs

Clinical studies testing treatments for severe COVID-19 face major delays due to eligibility issues.
Read More
Proteins & Antibodies

Bispecific CAR-T Cell Therapies: Successful Applications in Mouse Tumour Models

Two roadblocks to the successful application of treatments for tumourous tissues are heterogenous antigen expression and antigen loss. Bispecific CAR-T cells, capable of simultaneously binding to two different antigens via heavy chain-only domains, may present a solution.
Read More
Vaccines

FDA Approves GSK’s MMR Vaccine

The FDA gives the green light to GSK’s measles, mumps, and rubella vaccine, providing US clinicians with a new treatment option for childhood inoculation for first time in more than 50 years.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics